The role of interleukin-33 in patients with mild cognitive impairment and Alzheimer’s disease

BACKGROUND: The neuroprotective role of interleukin (IL)-33 is supported by numerous preclinical studies, but it remains uninvestigated in clinical studies of Alzheimer’s disease (AD). We aimed to examine the association between human blood levels of IL-33 and cognitive preservation in amnestic mild...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Chih-Sung, Su, Kuan-Pin, Tsai, Chia-Lin, Lee, Jiunn-Tay, Chu, Che-Sheng, Yeh, Ta-Chuan, Su, Ming-Wei, Lin, Guan-Yu, Lin, Yu-Kai, Chu, Hsuan-Te, Tsai, Chia-Kuang, Yang, Fu-Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367330/
https://www.ncbi.nlm.nih.gov/pubmed/32678011
http://dx.doi.org/10.1186/s13195-020-00652-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367330/
https://www.ncbi.nlm.nih.gov/pubmed/32678011
http://dx.doi.org/10.1186/s13195-020-00652-z

Ejemplares similares